title: [Small intestine transplantation].
abstract: Since the development of new immunosuppressive agents, as FK506, the results of small bowel transplantation have greatly improved. The patient survival at one year has increased from 25% during the cyclosporin era to 65% in 1995 and the graft survival from 19% to 57% respectively. Clearly, the postoperative complications are still frequent and severe and do not allow a wide generalisation of this method. However, total parental nutrition is not an appropriate solution for the long term management of patients with terminal intestinal insufficiency. In Switzerland, these patients survive for several years and finally die of problems that small bowel transplantation could already successfully overpass.
authors.affiliation: Département de chirurgie, Hôpitaux universitaires, Genève.
authors.forename: P
authors.initials: P
authors.lastname: Charbonnet
authors.forename: L
authors.initials: L
authors.lastname: Bühler
authors.forename: Z
authors.initials: Z
authors.lastname: Kadry
authors.forename: P
authors.initials: P
authors.lastname: Majno
authors.forename: P
authors.initials: P
authors.lastname: Morel
mesh_terms: D000328:Adult; D002648:Child; D003524:Cyclosporins / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007410:Intestinal Diseases / Q000601:surgery* / Q000628:therapy; D007421:Intestine, Small / Q000637:transplantation*; D009747:Nutritional Physiological Phenomena; D010289:Parenteral Nutrition, Total; D011183:Postoperative Complications / Q000209:etiology / Q000628:therapy
chemical_list: D003524:Cyclosporins; D007166:Immunosuppressive Agents